Nationwide surveillance of bacterial respiratory pathogens conducted by the Surveillance Committee of Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Clinical Microbiology in 2009: General view of the pathogens' antibacterial susceptibility

Journal of Infection and Chemotherapy

Volumn 18, Issue 5, 2012, Pages 609-620

  Watanabe, Akira ^a   Yanagihara, Katsunori ^a,b   Matsumoto, Tetsuya ^a   Kohno, Shigeru ^a,b   Aoki, Nobuki ^a,c   Oguri, Toyoko ^a   Sato, Junko ^a   Muratani, Tetsuro ^a   Yagisawa, Morimasa ^a   Ogasawara, Kazuhiko ^a   Koashi, Naoto ^a   Kozuki, Tsuneo ^a   Komoto, Akira ^a   Takahashi, Yoshisaburo ^a   Tsuji, Toshikatsu ^a   Terada, Michinori ^a   Nakanishi, Kunio ^a   Hattori, Rikizo ^a   Hirako, Yukio ^a   Maruo, Akinori ^a   Minamitani, Shinichi ^a   Morita, Kohei ^a   Wakamura, Tomotaro ^a   Sunakawa, Keisuke ^a   Hanaki, Hideaki ^d   Ohsaki, Yoshinobu ^e   Honda, Yasuhito ^f   Sasaoka, Shoichi ^g   Takeda, Hiroaki ^h   Ikeda, Hideki ⁱ   Sugai, Atsuko ⁱ   Miki, Makoto ^j   Nakanowatari, Susumu ^j   Takahashi, Hiroshi ^k   Utagawa, Mutsuko ^k   Kobayashi, Nobuyuki ^l   Takasaki, Jin ^l   Konosaki, Hisami ^l   Aoki, Yasuko ^m   Shoji, Michi ^m   Goto, Hajime ⁿ   Saraya, Takeshi ⁿ   Kurai, Daisuke ⁿ   Okazaki, Mitsuhiro ⁿ   Kobayashi, Yoshio ^o   Katono, Yasuhiro ^o   Kawana, Akihiko ^p   Saionji, Katsu ^p   Miyazawa, Naoki ^q   Sato, Yoshimi ^q   Watanuki, Yuji ^q   Kudo, Makoto ^q   Ehara, Shigeru ^q   Tsukada, Hiroki ^r   Imai, Yumiko ^r   Watabe, Nobuei ^r   Aso, Sakura ^r   Honma, Yasuo ^c   Mikamo, Hiroshige ^s   Yamagishi, Yuka ^s   Takesue, Yoshio ^t   Wada, Yasunao ^t   Nakamura, Tadahiro ^u   Mitsuno, Noriko ^u   Mikasa, Keiichi ^v   Kasahara, Kei ^v   Uno, Kenji ^v   Sano, Reiko ^v   Miyashita, Naoyuki ^w   Kurokawa, Yukinori ^w   Takaya, Mariko ^w   Kuwabara, Masao ^x   Watanabe, Yaeko ^x   Doi, Masao ^x   Shimizu, Satomi ^w   Negayama, Kiyoshi ^y   Kadota, Junichi ^a,z   Hiramatsu, Kazufumi ^y   Morinaga, Yoshitomo ^b   Honda, Junichi ^aa   Fujita, Masaki ^ab   Iwata, Satoshi ^a   Iwamoto, Aikichi ^a   Ezaki, Takayuki ^a   Onodera, Shoichi ^a   Kusachi, Shinya ^a   Tateda, Kazuhiro ^a   Tanaka, Michio ^a   Totsuka, Kyoichi ^a   Niki, Yoshihito ^a   Matsumoto, Tetsuro ^a   more..

^a C/o Japanese Society of Chemotherapy ^*  (Japan)

^b NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Shinrakuen Hospital   (Japan)

^d KITASATO INSTITUTE   (Japan)

^e ASAHIKAWA MEDICAL COLLEGE   (Japan)

^f NTT CORPORATION   (Japan)

^g Muroran General Hospital   (Japan)

^h Yamagata Saisei Hospital   (Japan)

ⁱ Sanyudo Hospital   (Japan)

^j Sendai Red Cross Hospital   (Japan)

^k Saka General Hospital   (Japan)

^l NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^m NATIONAL HOSPITAL ORGANIZATION TOKYO MEDICAL CENTER   (Japan)

ⁿ KYORIN UNIVERSITY   (Japan)

^o KEIO UNIVERSITY HOSPITAL   (Japan)

^p NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^q YOKOHAMA CITY UNIVERSITY HOSPITAL   (Japan)

^r NIIGATA CITY GENERAL HOSPITAL   (Japan)

^s AICHI MEDICAL UNIVERSITY HOSPITAL   (Japan)

^t HYOGO COLLEGE OF MEDICINE   (Japan)

^u OSAKA CITY GENERAL HOSPITAL   (Japan)

^v NARA MEDICAL UNIVERSITY   (Japan)

^w KAWASAKI MEDICAL SCHOOL   (Japan)

^x HIROSHIMA PREFECTURAL HOSPITAL   (Japan)

^y KAGAWA UNIVERSITY HOSPITAL   (Japan)

^z OITA UNIVERSITY   (Japan)

^aa ST MARY S HOSPITAL   (Japan)

^ab FUKUOKA UNIVERSITY   (Japan)

more..

Author keywords

Resistance; Respiratory tract infection; Surveillance; Susceptibility

Indexed keywords

EXTENDED SPECTRUM BETA LACTAMASE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL STRAIN; CONTROLLED STUDY; HAEMOPHILUS INFLUENZAE; JAPANESE; KLEBSIELLA PNEUMONIAE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MORAXELLA CATARRHALIS; NONHUMAN; PSEUDOMONAS AERUGINOSA; REVIEW; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES;

EID: 84871400356     PISSN: 1341321X     EISSN: 14377780     Source Type: Journal    
DOI: 10.1007/s10156-012-0434-3     Document Type: Article

References (10)

1. Niki Y, Hanaki H, Matsumoto T, Yagisawa M, Kohno S, Aoki N, et al. Nationwide surveillance of bacterial respiratory pathogens conducted by the Japanese Society of Chemotherapy in 2008: general view of the pathogens' antibacterial susceptibility. J Infect Chemother. 2011;17(4):510-23.
2. CLSI. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard. 7th ed. Wayne: Clinical and Laboratory Standards Institute; 2006. p. M7-A7
3. CLSI. Performance standards for antimicrobial susceptibility testing: 19th informational supplement. Wayne: Clinical and Laboratory Standards Institute; 2008. p. M100-S18
4. Jenkins SG, Farrell DJ, Patel M, Lavin BS. Trends in anti-bacterial resistance among Streptococcus pneumoniae isolated in the USA, 2000-2003: PROTEKT US years 1-3. J Infect. 2005;51(5): 355-63.
5. Barada K, Hanaki H, Ikeda S, Yamaguchi Y, Akama H, Nakae T, et al. Trends in the gentamicin and arbekacin susceptibility of methicillin-resistant Staphylococcus aureus and the genes encoding aminoglycoside-modifying enzymes. J Infect Chemother. 2007;13(2):74-8.
6. Mochizuki T, Okamoto N, Yagishita T, Takuhiro K, Mashiko K, Ogawa F, et al. Analysis of antimicrobial drug resistance of Staphylococcus aureus strains by WHONET 5: microbiology laboratory database software. J Nihon Med Sch. 2004;71(5): 345-51.
7. Hasegawa K, Kobayashi R, Takada E, Ono A, Chiba N, Morozumi M, et al. High prevalence of type b beta-lactamasenon-producing ampicillin-resistant Haemophilus influenzae in meningitis: the situation in Japan where Hib vaccine has not been introduced. J Antimicrob Chemother. 2006;57(6):1077-82.
8. Yagi T, Kurokawa H, Shibata N, Shibayama K, Arakawa Y. A preliminary survey of extended-spectrum beta-lactamases (ESBLs) in clinical isolates of Klebsiella pneumoniae and Escherichia coli in Japan. FEMS Microbiol Lett. 2000;184(1):53-6.
9. Yamaguchi K, Ishii Y, Iwata M, Watanabe N, Uehara N, Yasujima M, et al. Nationwide surveillance of parenteral antibiotics containing meropenem activities against clinically isolated strains in 2006. Jpn J Antibiot. 2007;60(6):344-77.
10. Yamaguchi K, Ohno A, Ishii Y, Tateda K, Iwata M, Kanda M, et al. In vitro susceptibilities to levofloxacin and various antibacterial agents of 12,919 clinical isolates obtained from 72 centers in 2007. Jpn J Antibiot. 2009;62(4):346-70.